Pear Therapeutics raises $64 million

After receiving FDA last month for its prescription software to treat opioid addiction, Pear Therapeutics has posted $64 million in new fundraising.

The reSET-O prescription digital therapeutic for opioid use disorder consists of a 12-week cognitive behavioral therapy program along with outpatient treatment. It includes buprenorphine, a standard medication for opioid addiction, while helping to reinforce positive behaviors through interactive therapy lessons.

Click here to view the entire article.